Trade Summary

5 days ago, Nouri Alaleh, serving as EVP, CLO, CORP. SEC. at Procept Biorobotics Corp (PRCT), sold 3,243 shares at $25.65 per share, for a total transaction value of $83,197.00. Following this transaction, Nouri Alaleh now holds 111,021 shares of PRCT.

This sale represents a 3.00% decrease in Nouri Alaleh's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Procept Biorobotics Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.